JP

Jon Peers

Director of Sustainability Hovione · Teva Active Pharmaceutical Ingredients

Madrid, Community of Madrid

In My Own Words

A passionate leader who drives new ideas and solutions into creating tangible business benefit coupled with positive environmental and social impact. A creative thinker and coalition builder who delivers EHS & Sustainability behavioral awareness and knowledge at all levels. A strong communicator leveraging vision, strategy and integration with over 20 years experience in the manufacturing sector.

Work Experience

Environmental Director (Madrid)

Teva Active Pharmaceutical Ingredients

2019 – Present

A stand-alone unit within Teva Pharmaceutical Industries with the industry's broadest portfolio of more than 400 high quality API products with 16 production facilities located in Italy, Hungary, the Czech Republic, Croatia, Israel, India, China, Mexico, and the United States. Responsible for: • Managing internal and external compliance with current key projects including: - Solid Waste & WWTP Optimisation and cost reduction opportunities - Driving Global IH program improvements for risk assessment and monitoring - VOC Reduction programs for India - Supporting Teva Social Impact Goals and Targets

Teva Pharmaceuticals, Global EHS - Director Environment & Sustainability (Madrid) Global responsibility and support for: • Managing compliance matters and environmental liability • Driving sustainability with a focus on greenhouse gas and waste • Supporting external reporting, CDP, Ecovadis, customer queries

Associate Director Environment & Health, Europe

Teva Pharmaceuticals

2015 – 2016

Responsible for 18 Pharma, Biologic and Sterile manufacturing facilities throughout Europe, Russia and Israel. Focused on the development and implementation of new global EHS requirements and external stakeholder engagement with EU policy development related to Pharmaceuticals in the environment. Key achievements include: • Authoring several Global EHS standards, specifications and guidance to support the new EHSMS; • Gap analysis across all global pharmaceutical manufacturing locations to assess containment status for potent compounds and develop strategic action plan based on network strategy;

Committee Member

EPS

2016 – 2016

related to Pharmaceuticals in the Environment (PiE) (http://www.medicinesforeurope.com/wp-content/uploads/2016/03/EPS-CORE_V9.compressed.pdf) and EFPIA EHS Workstream. • Committee Member of the Pharmaceutical Supply Chain Initiative (PSCI) Communication team (https://pscinitiative.org). Key achievements include: • Review of Teva first generation Environment and Sustainability Goals to develop next generation; • Part of internal team initiating Responsible Supply Chain program; • Partnered with Global Procurement to drive packaging material sourcing model that delivers sustainability benefits and cost savings; • Developed waste strategy to reduce waste vendor liability while identifying (10%) global cost reductions.

European EHS Manager (Madrid)

Abbott Laboratories, Abbott Nutrition Supply Chain

2010 – 2015

Responsible for European Operations across 6 locations including Logistics, Office, Manufacturing and R&D ranging from 200 to 500FTE including manufacturing sites accredited to ISO 14,001 & OSHAS 18001 Management Standards. Experience in providing EHS support across North America and Asia. Key achievements: • Successive regional reduction in workplace recordable injury rates from 0.42 to 0.22 ; • 2 manufacturing facilities +2 years Lost Time Accident Free; • Development and Implementation of Behaviour Based Safety Program across Europe and China; • Zero EHS government/local authority fines or citations or ISO 14,001/OSHAS 18,001 Management System major findings; • Increased EU recycling rates from 54% to 78% - with only 2% of waste going to landfill; • Managed $3.2 Million (USD) Global EHS Capital Expenditure Program.

Occupational & Safety Specialist (London & Madrid)

Abbott Laboratories, Abbott Nutrition Supply Chain

2004 – 2010

Specialised in Occupational Hygiene and Safety whilst providing multi-disciplinary EHS support to 22 Abbott Manufacturing sites throughout Europe in varying business units. (Pharmaceutical, Diagnostics, Vascular and Nutritional). Provided facility support in topic areas such as: • Development of Global technical standards, implementation and training. • Regulatory Audit assessments within Europe and North America; • ISO 14001/OSHAS 18001 preparation and support; • Development of site risk assessment profiles for safety critical areas and management system implementation; and • Implementation of occupational hygiene programs and exposure monitoring protocols. • Global EHS IT projects

Education

BSc (Hons)

University of Bradford

BSc (Hons)

University of George Washington